By Jennifer Reed

Canine influenza virus, also known as CIV or dog flu, is a highly contagious respiratory disease similar to the human flu virus. After careful consideration following an increased incidence of the disease in the United States earlier this year, The Drake Center is now recommending a preventative vaccine for high-risk patients. The vaccine will be available at The Drake Center starting November 1.

CIV is most commonly spread via direct nose-to-nose contact with infected dogs or contaminated objects. This disease cannot be transmitted to humans; however, humans can help spread the virus from one dog to another.

The symptoms of CIV are similar to those of the flu in humans, including:

  • Coughing
  • Sneezing
  • Nasal discharge
  • Fever
  • Lethargy
  • Lack of appetite

 

Treatment for CIV consists mostly of supportive care, such as medication or IV fluids, while the virus runs its course. For severe infections, hospitalization and additional treatment may be needed.

The canine influenza vaccine has been proven to significantly reduce the clinical signs of CIV, including coughing, sneezing, discharge from the eyes and nose and lethargy. It has also been shown to reduce the severity and spread of the disease.

At The Drake Center, we recommend the CIV vaccine for all dogs that frequently visit kennels, dog parks, puppy classes, dog shows, boarding or grooming facilities or regularly participate in any gatherings with multiple dogs.

Remember, the best way to protect your pet and others from disease is with prevention. The canine influenza vaccine is given in two doses two to four weeks apart the first year, followed by an annual booster. This will help keep your dog safe and reduce the incidence of CIV by preventing the spread of bacteria.

For more information about CIV, please contact The Drake Center at (760) 456-9556 or [email protected].

Additional information about the canine influenza vaccine can be found at www.doginfluenza.com.